Related Experiment Video
Updated: Jun 25, 2025
04:05
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
1.8K
The Congestion "Pandemic" in Acute Heart Failure Patients
Daniela Mocan1, Radu Ioan Lala1,2, Maria Puschita1
1Multidisciplinary Doctoral School, Vasile Goldis Western University of Arad, 310025 Arad, Romania.
Biomedicines
|May 25, 2024
Summary
Congestion is a key sign of acute heart failure (AHF) and a major cause of hospitalizations. Understanding congestion phenotypes and improving decongestion strategies are crucial for better patient outcomes.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Science
Background:
- Congestion is a primary driver of hospital admissions, rehospitalizations, and mortality in acute heart failure (AHF).
- Congestion presents diverse phenotypes in acute settings, including volume overload, volume redistribution, or both.
- Achieving complete decongestion in AHF patients is difficult, with over half experiencing residual congestion at discharge.
Purpose of the Study:
- To enhance understanding of the congestion phenomenon in patients with AHF.
- To explore pathophysiological mechanisms underlying congestion.
- To review novel diagnostic and management tools for efficient decongestion.
Main Methods:
- Literature review focusing on acute heart failure congestion.
- Analysis of pathophysiological mechanisms of congestion.
- Evaluation of current and emerging diagnostic and management strategies.
Main Results:
- Residual congestion post-discharge is a significant predictor of adverse cardiovascular events and poor outcomes.
- Different congestion phenotypes necessitate tailored therapeutic approaches for effective decongestion.
- Emerging tools offer potential for improved diagnosis and management of congestion.
Conclusions:
- Recognizing and addressing congestion phenotypes is critical for optimizing AHF treatment.
- Efficient decongestion strategies are essential to reduce rehospitalization and mortality in AHF.
- Further research into advanced diagnostic and management tools is needed to improve decongestion efficacy.
More Related Videos
Related Concept Videos
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:21Acute Respiratory Failure-II
210
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
210
01:30Acute Respiratory Failure-III
178
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
178
01:21Acute Respiratory Failure-I
198
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
198
01:29Acute Respiratory Failure-V
132
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
132